Cavatorta Says Luxottica’s Strategy On Track, Company to Re-examine ROI, New Co-CEO to Come From Outside

By Staff
Monday, September 01, 2014 2:14 PM MILAN—In a conference call with financial analysts here following Luxottica’s announcement of a new co-CEO structure for corporate and markets functions and the departure of Andrea Guerra, as previously reported by VMail today, new CEO Enrico Cavatorta reiterated that the company’s strategic direction remains constant, adding that any disagreements between former CEO Guerra and Luxottica founder and chairman, Leonardo Del Vecchio and the company’s board “had more to do with differences of opinion over the approach of the shared CEO structure and the new organizational model rather than any other issue.”

Luxottica Sets New Co-CEO Model, Guerra to Leave, Cavatorta Named CEO Corporate, Interim CEO Markets

By Staff
Monday, September 01, 2014 10:30 AM MILAN—Following a board meeting here today, Luxottica Group S.p.A. (NYSE: LUX; MTA: LUX), announced the introduction of a new management structure based on a co-CEO model, one focused on Markets and the other dedicated to Corporate Functions.

7 to 9 AM

By Staff
Monday, September 01, 2014 12:09 AM

9 to 11 AM

By Staff
Monday, September 01, 2014 12:08 AM

11 to 1 PM

By Staff
Monday, September 01, 2014 12:07 AM

1 to 2 PM

By Staff
Monday, September 01, 2014 12:05 AM

2 to 3 PM

By Staff
Monday, September 01, 2014 12:05 AM

3 to 4 PM

By Staff
Monday, September 01, 2014 12:04 AM

4 to 5 PM

By Staff
Monday, September 01, 2014 12:03 AM

5 to 7 PM

By Staff
Monday, September 01, 2014 12:02 AM

A Day in the Life... Optical Across America

By Staff
Monday, September 01, 2014 12:01 AM At Vision Monday, we see how vast and manifold the optical industry is every single day, but outside of a trade show, like this month’s Vision Expo West in Las Vegas, the rest of the industry is rarely afforded the same privilege.

Allergan Requests Calif. Court Block Valeant/Pershing Square From Voting Shares; Sets New Dec. 18 Date for Special Meeting

By Staff
Friday, August 29, 2014 12:30 AM IRVINE, Calif.— Allergan, Inc. (NYSE: AGN) has asked the United States District Court for the Central District of California to set an expedited schedule for discovery and a motion for a preliminary injunction against Valeant Pharmaceuticals (NYSE: VRX), Pershing Square Capital Management, L.P. and its principal, William A. Ackman, for violations of the federal securities laws, according to an announcement from Allergan.

Alcon to Acquire WaveTec Vision, Developer of Intra-Operative Measurements for Cataract Surgery

By Staff
Friday, August 29, 2014 12:24 AM FORT WORTH, Texas – Alcon, division of Novartis Group (NYSE: NVS), announced this week that the company has entered into an agreement to acquire Aliso Viejo, Calif.-based WaveTec Vision, a privately-held company that developed the ORA System, the first commercialized intra-operative guidance system for cataract surgeons implanting intra-ocular lenses (IOLs).

Carrier Appointed COO Essilor Int'l, Leonard Named President, EOA

By Staff
Thursday, August 28, 2014 6:15 AM PARIS— Essilor International announced today that John Carrier, president and CEO of Essilor of America, has been appointed COO of Essilor International, alongside Paul du Saillant and Laurent Vacherot who are long-time co-COOs.

Jan Cory Named New U.S. President of Silhouette Optical Ltd.

By Staff
Monday, August 25, 2014 12:30 AM ALBANY, N.Y.—Jan Cory, an experienced eyewear executive, has been named the new U.S. president of Silhouette Optical, Ltd.
Loading...